When was CTIBiotech founded?

CTIBiotech was founded in 2009 and raised its 1st funding round 17 years after it was founded.

Where is CTIBiotech located?

CTIBiotech is headquartered in Lyon, France.

How many employees does CTIBiotech have?

As of Aug 31, 2026, the latest employee count at CTIBiotech is 24.

Is CTIBiotech a funded company?

CTIBiotech is a funded company, having raised a total of $***** in its 1st and only funding round, a Grant (prize money) round on Apr 28, 2026.

When was the latest funding round of CTIBiotech?

CTIBiotech's latest funding was a $***** Grant (prize money) round on Apr 28, 2026, with participation from 2 investors. Its primary sector is Life Sciences Platforms and Tools. In France, the Life Sciences Platforms and Tools sector has seen $13.2M in funding in 2026 to date.

Where does CTIBiotech rank among its competitors?

CTIBiotech ranks 11th amongst 100 active competitors, of which 20 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was CurifyLabs, which secured $14M in Jul, 2026.

Who are the top competitors of CTIBiotech?

CTIBiotech's top competitors include Xlife sciences, CurifyLabs and Prellis Biologics. Among them, CurifyLabs secured the most recent funding round in July, 2026.

CTIBiotech - 2026 Company Profile, Team, Funding & Competitors

Company Details

CTIBiotech is a developer of 3D human tissue models for the pharmaceutical industry and dermato-cosmetics sectors. The company also claims of printing cancer tissues in 3D using the tools in bioengineering. It offers 3D tissue and cell models to the pharmaceutical industry for cancer research, regenerative medicine, medical devices, public and private research institutions, and organizations. Offers human biological sample procurement & cell harvesting.

Website: ctibiotech.com
Social
Phone Number: +33 **********

Key Metrics

Founded Year

2009

Location

Lyon, France

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Apr 28, 2026, $*****

Investors

Bpifrance & 1 more

Ranked

11^th among 100 active competitors

Employee Count

24 as on Aug 31, 2026

Similar Companies

Xlife sciences & 119 more

View CTIBiotech's full profile

CTIBiotech has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Apr 28, 2026 for $*****. 2 investors participated in its latest round. CTIBiotech has 2 institutional investors.

Here is the list of recent funding rounds of CTIBiotech:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 28, 2026	5492260	Grant (prize money)	8899222	9126308	7381864	1512638

Access funding benchmarks and valuations. Sign up today!

View details of CTIBiotech's funding rounds and investors

CTIBiotech's employee count trend

CTIBiotech has 24 employees as of Aug 26. Here is CTIBiotech's employee count trend over the years:

Uncover CTIBiotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CTIBiotech include Xlife sciences, CurifyLabs and Prellis Biologics. Here is the list of Top 10 competitors of CTIBiotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Xlife sciences 2013, Zurich (Switzerland), Public	Developer of drugs for multiple diseases	$62.8M	-	58/100
2nd	CurifyLabs 2021, Helsinki (Finland), Series A	Provider of digital 3D printing solutions for personalized medicine	$33.8M	Healthcap, Springvest & 8 others	57/100
3rd	Prellis Biologics 2016, San Francisco (United States), Series C	Provider of 3D bioprinting technology to build human tissues for drug development	$70.1M	Celesta Capital, Khosla Ventures & 12 others	57/100
4th	ROKIT Healthcare 2012, Seoul (South Korea), Public	Provider of 4D bio-printer solutions for tissue regenerative	$30M	DRADS Capital, Korean Development Bank & 16 others	54/100
5th	Shibuya Kogyo 1931, Kanazawa (Japan), Public	Technology for biological 3D printing	-	Nagoya Small and Medium Business Investment & Consultation ... Read more	53/100
6th	Lattice Medical 2017, Loos (France), Series B	Provider of 3D-printed technology for soft tissue reconstruction	$63.4M	EIC Fund, Bpifrance & 8 others	49/100
7th	3D Bio Corporation 2014, New York City (United States), Series A	3D Bio-printed living tissues	$5.03M	Kairos Ventures, Blue Collective & 9 others	48/100
8th	Allevi 2014, Philadelphia (United States), Acquired	3D bioprinting solutions: bioprinters, bioinks, and software for tissue engineering	$2.33M	500 Global, Ben Franklin Technology Partners ... & 14 others	47/100
9th	Dimension Inx 2017, Chicago (United States), Series A	Provider of 3D bio materials for regenerative medicine	$17.6M	Prime Movers Lab, KdT Ventures & 11 others	47/100
10th	FabRx 2014, London (United Kingdom), Unfunded	3D printed drugs	-	-	47/100
11th	CTIBiotech 2009, Lyon (France), Funding Raised	Develops 3D human tissue models	-	Government of France, Bpifrance	46/100